This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2001-2006.
Company Filing History:
Years Active: 2001-2006
Title: The Innovative Contributions of Karen Gray
Introduction
Karen Gray is a notable inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of human pathology and physiology through her innovative research. With a total of 2 patents, her work focuses on the role of adrenomedullin (AM) in cancer and pancreatic physiology.
Latest Patents
Karen Gray's latest patents include groundbreaking research on the functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology. The methods of her invention demonstrate that adrenomedullin is expressed in human cancer cell lines of diverse origin and functions as a universal autocrine growth factor driving neoplastic proliferation. Her patents provide AM peptides and AM antibodies that are useful in therapeutic, pharmacologic, and physiologic compositions. Additionally, her work outlines methods for the diagnosis, treatment, and prevention of diseases utilizing these compositions. The experimental models she developed have shown that AM inhibits insulin secretion in a dose-dependent manner. Notably, the monoclonal antibody MoAb-G6, which neutralizes AM bioactivity, was shown to increase insulin release fivefold, an effect that was reversed by the addition of synthetic AM.
Career Highlights
Karen Gray is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this prestigious institution has allowed her to contribute significantly to medical research and innovation.
Collaborations
Some of her notable coworkers include Alfredo Martinez and Mae Jean Miller, who have collaborated with her on various research projects.
Conclusion
Karen Gray's innovative work in the field of human pathology and physiology has led to significant advancements in understanding the role of adrenomedullin in cancer and pancreatic function. Her contributions continue to impact the medical research community positively.